Floatz logo

MOXIFLOXACIN

Precancerous Condition

European Organisation for Research and Treatment of Cancer - EORTCSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Precancerous Condition cohort.

Asset / SponsorPhaseRating
Darbepoetin Alfa
Mayo Clinic
Phase 3BB
Epoetin Alfa
Mayo Clinic
Phase 3BB
Cyclophosphamide
Institut Paoli-Calmettes
Phase 2BB
CYCLOSPORIN A
Institut Paoli-Calmettes
Phase 2BB
Fludarabine
Institut Paoli-Calmettes
Phase 2BB

View all 50 →

Same molecule, other indications

MOXIFLOXACIN is also rated in:

bacterial infectious disease with sepsisDormant
BB
Indicative ·
64 / 100
View asset →
Hodgkins lymphomaDormant
B
Indicative ·
62 / 100
View asset →
plasma cell myelomaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →